Top Markets
Coin of the day
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

RP
Pozycja w akcjach #38777
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Cena akcji
$0.01100905
Ostatnia synchronizacja: 2025-02-28
Kapitalizacja rynkowa
$810.02K
Zmiana (1 dzień)
58.98%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel RepliCel Life Sciences Inc. (RP)

Kategoria

Historia ceny akcji dla RepliCel Life Sciences Inc. (RP)
Najwyższa cena zamknięcia: $0.01 dnia 2025-02-01

Najniższa cena zamknięcia: $5.57 dnia 2014-01-01
Historia cen akcji firmy RepliCel Life Sciences Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2025 5.41%
2024 -86.30%
2023 -17.08%
2022 -66.62%
2021 21.78%
2020 -10.89%
2019 -28.16%
2018 -23.07%
2017 -43.43%
2016 -67.50%
2015 -35.87%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$506.92 29.88%
US
$843.33 29.26%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE